Gift Nifty was trading around 23,495 level, a discount of nearly 105 points from the Nifty futures’ previous close, ...

Own stocks of companies that get drugs approved. That hasn’t been so easy. But the U.S. Food & Drug Administration (FDA) has ...

High-yield dividend stocks have been gaining momentum ahead of potential Fed rate cuts. Here's why these two high-yield ...

Though the strategic shift allows pharma to offer integrated health solutions, diversify revenue and improve patient outcomes ...

Hims & Hers Health, Inc. (“Hims & Hers”) (NYSE: HIMS), the leading health and wellness platform, today announced Deb Autor, ...

MedGenome: Genomic tests, now becoming as routine as pathology and imaging, are poised to enhance early detection of both ...

A U.S. stock rally fueled by Donald Trump’s election victory is stumbling, as investors contend with everything from renewed ...

Wall Street continues its decline on Friday following the Fed Chairman’s hawkish statement on rate cut. Moreover, President-elect Donald Trump’s decision to elect a vaccine skeptic as the head of the ...

For young, healthy people who may be wondering, “do I need a COVID booster at all?”, having one annually is sensible.

RNA vaccines saved lives during the COVID-19 pandemic, but older people had less of an immune response to the vaccines than did younger adults. Why? Boston Children's researchers, led by Byron Brook, ...

A woman sued Pfizer, alleging the birth control shot Depo-Provera caused her brain tumors, following a study linking the drug ...

Pfizer's stock dropped 4.3 percent while Moderna's fell 3.1 percent and Novavax saw a 2.8 percent dip in its stock Friday ...